Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Changlin Wan

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
BMC Bioinformatics|October 5, 2017
Anaconda: AN automated pipeline for somatic COpy Number variation Detection and Annotation from tumor exome sequencing dataJianing Gao, Changlin Wan, Huan Zhang, et al.
Nucleic Acids Research|August 3, 2019
LTMG: a novel statistical modeling of transcriptional expression states in single-cell RNA-Seq dataChanglin Wan, Wennan Chang, Yu Zhang, et al.
Briefings in Bioinformatics|November 24, 2020
SSMD: a semi-supervised approach for a robust cell type identification and deconvolution of mouse transcriptomics dataXiaoyu Lu, Szu-Wei Tu, Wennan Chang, et al.
Computational and Structural Biotechnology Journal|April 4, 2023
Pipeline for characterizing alternative mechanisms (PCAM) based on bi-clustering to study colorectal cancer heterogeneitySha Cao, Wennan Chang, Changlin Wan, et al.
Genome Research|July 24, 2021
A graph neural network model to estimate cell-wise metabolic flux using single-cell RNA-seq dataNorah Alghamdi, Wennan Chang, Pengtao Dang, et al.
The Journal of Clinical Investigation|September 29, 2020
MAL2 drives immune evasion in breast cancer by suppressing tumor antigen presentationYuanzhang Fang, Lifei Wang, Changlin Wan, et al.
The Journal of Clinical Investigation|April 8, 2021
Atractylenolide I enhances responsiveness to immune checkpoint blockade therapy by activating tumor antigen presentationHanchen Xu, Kevin Van der Jeught, Zhuolong Zhou, et al.
The Journal of Clinical Investigation|January 16, 2026
Retraction for Atractylenolide I enhances responsiveness to immune checkpoint blockade therapy by activating tumor antigen presentationHanchen Xu, Kevin Van der Jeught, Zhuolong Zhou, et al.
The Journal of Clinical Investigation|May 1, 2026
Amendment to Atractylenolide I enhances responsiveness to immune checkpoint blockade therapy by activating tumor antigen presentationHanchen Xu, Kevin Van der Jeught, Zhuolong Zhou, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
BMC Bioinformatics|October 5, 2017
Anaconda: AN automated pipeline for somatic COpy Number variation Detection and Annotation from tumor exome sequencing dataJianing Gao, Changlin Wan, Huan Zhang, et al.
Nucleic Acids Research|August 3, 2019
LTMG: a novel statistical modeling of transcriptional expression states in single-cell RNA-Seq dataChanglin Wan, Wennan Chang, Yu Zhang, et al.
Briefings in Bioinformatics|November 24, 2020
SSMD: a semi-supervised approach for a robust cell type identification and deconvolution of mouse transcriptomics dataXiaoyu Lu, Szu-Wei Tu, Wennan Chang, et al.
Computational and Structural Biotechnology Journal|April 4, 2023
Pipeline for characterizing alternative mechanisms (PCAM) based on bi-clustering to study colorectal cancer heterogeneitySha Cao, Wennan Chang, Changlin Wan, et al.
Genome Research|July 24, 2021
A graph neural network model to estimate cell-wise metabolic flux using single-cell RNA-seq dataNorah Alghamdi, Wennan Chang, Pengtao Dang, et al.
The Journal of Clinical Investigation|September 29, 2020
MAL2 drives immune evasion in breast cancer by suppressing tumor antigen presentationYuanzhang Fang, Lifei Wang, Changlin Wan, et al.
The Journal of Clinical Investigation|April 8, 2021
Atractylenolide I enhances responsiveness to immune checkpoint blockade therapy by activating tumor antigen presentationHanchen Xu, Kevin Van der Jeught, Zhuolong Zhou, et al.
The Journal of Clinical Investigation|January 16, 2026
Retraction for Atractylenolide I enhances responsiveness to immune checkpoint blockade therapy by activating tumor antigen presentationHanchen Xu, Kevin Van der Jeught, Zhuolong Zhou, et al.
The Journal of Clinical Investigation|May 1, 2026
Amendment to Atractylenolide I enhances responsiveness to immune checkpoint blockade therapy by activating tumor antigen presentationHanchen Xu, Kevin Van der Jeught, Zhuolong Zhou, et al.
Pageof 2